Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

In the last two years, Merck has beaten EPS estimates 88% of the time, and revenue estimates 100% of the time. Meanwhile, ...

The stock's rise snapped a three-day losing streak.

Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that ...

We recently published a list of 20 Best Stock To Buy According to Marjorie Taylor Greene. In this article, we are going to ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Merck (NYSE:MRK) with a Neutral recommendation ...

Analysts' ratings for Merck & Co (NYSE:MRK) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a snapshot of their recent ratings, showcasing ...

Lamar Jackson and Dale Earnhardt may have butted heads over the number 8, but in some types of logos, it turns out the ...